Latest Articles

  • Reviewers 2014
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 161;
  • Pneumatosis cystoides intestinalis: Is surgery always indicated?
    Dayakar Kancherla, MD, Swapna Vattikuti, MD and Kishore Vipperla, MD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 151-152; DOI: https://doi.org/10.3949/ccjm.82a.14006

    This disease is usually benign, but evidence of necrosis or pneumoperitoneum warrants immediate surgery.

  • Diabetes therapy and cardiac risk (November 2014)
    David Bell, MB
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 140; DOI: https://doi.org/10.3949/ccjm.82c.03001

    A reader comments on diabetes therapy and cardiac risk (November 2013).

  • Outcome measures need context
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 138-139; DOI: https://doi.org/10.3949/ccjm.82b.03015

    The patient in front of me may differ from those seen in a clinical trial and may care about other outcome measures.

  • Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists?
    Subramanian Kannan, MD and Christian Nasr, MD
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 142-144; DOI: https://doi.org/10.3949/ccjm.81a.13066

    The risk in humans is difficult to quantify, but low.

  • Managing aneurysmal subarachnoid hemorrhage: It takes a team
    Airton Leonardo de Oliveira Manoel, MD, David Turkel-Parrella, MD, Abhijit Duggal, MD, Amanda Murphy, MD, PhD, Victoria McCredie, MD, FRCPC and Thomas R. Marotta, MD, FRCPC
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 177-192; DOI: https://doi.org/10.3949/ccjm.82a.14021

    There is no silver bullet, but systematic application of small advances maximizes the patient’s chance of recovery.

  • In Reply: Diabetes therapy and cardiac risk (November 2014)
    Robert S. Zimmerman, MD and Kevin M. Pantalone, DO
    Cleveland Clinic Journal of Medicine March 2015, 82 (3) 140-141; DOI: https://doi.org/10.3949/ccjm.82c.03002

    A reader comments on diabetes therapy and cardiac risk (November 2013).

  • Should patients stop taking aspirin for primary prevention?
    Jeremiah P. Depta, MD, MPHS and Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
    Cleveland Clinic Journal of Medicine February 2015, 82 (2) 91-96; DOI: https://doi.org/10.3949/ccjm.82a.14114

    In view of the evidence, routine use of aspirin for primary prevention is not recommended, even in patients with diabetes.

  • Pulmonary tuberculosis (January 2015)
    Cleveland Clinic Journal of Medicine February 2015, 82 (2) 114;
  • Cystic lung disease: Systematic, stepwise diagnosis
    Duc Ha, MD, Ruchi Yadav, MD and Peter J. Mazzone, MD, MPH, FCCP
    Cleveland Clinic Journal of Medicine February 2015, 82 (2) 115-127; DOI: https://doi.org/10.3949/ccjm.82a.14020

    One can arrive at the likely diagnosis in most cases on the basis of the clinical and radiographic features.

Pages